DK51590A - System til topisk afgivelse - Google Patents

System til topisk afgivelse Download PDF

Info

Publication number
DK51590A
DK51590A DK051590A DK51590A DK51590A DK 51590 A DK51590 A DK 51590A DK 051590 A DK051590 A DK 051590A DK 51590 A DK51590 A DK 51590A DK 51590 A DK51590 A DK 51590A
Authority
DK
Denmark
Prior art keywords
delivery system
topical delivery
topical
delivery
Prior art date
Application number
DK051590A
Other languages
English (en)
Other versions
DK51590D0 (da
Inventor
Tully J Speaker
Frank N Chang
Stephen C Hsu
Original Assignee
Univ Temple
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Temple filed Critical Univ Temple
Publication of DK51590A publication Critical patent/DK51590A/da
Publication of DK51590D0 publication Critical patent/DK51590D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK051590A 1988-06-28 1990-02-27 System til topisk afgivelse DK51590D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/212,492 US4917892A (en) 1988-06-28 1988-06-28 Encapsulated topical delivery system
PCT/US1989/002643 WO1990000048A1 (en) 1988-06-28 1989-06-16 Topical delivery system

Publications (2)

Publication Number Publication Date
DK51590A true DK51590A (da) 1990-02-27
DK51590D0 DK51590D0 (da) 1990-02-27

Family

ID=22791250

Family Applications (1)

Application Number Title Priority Date Filing Date
DK051590A DK51590D0 (da) 1988-06-28 1990-02-27 System til topisk afgivelse

Country Status (9)

Country Link
US (1) US4917892A (da)
EP (1) EP0393164A4 (da)
JP (1) JPH03501485A (da)
AU (1) AU613298B2 (da)
DK (1) DK51590D0 (da)
NZ (1) NZ229356A (da)
PT (1) PT90994A (da)
WO (1) WO1990000048A1 (da)
ZA (1) ZA894308B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2659554B1 (fr) 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
AU629316B2 (en) * 1990-04-11 1992-10-01 Flora Inc. Periodontal disease treatment system
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
US5284663A (en) * 1991-07-23 1994-02-08 Temple University Salt film encapsulated perfluorocarbons
AU675206B2 (en) * 1991-09-13 1997-01-30 Gillette Canada Inc. Polymeric particles for dental applications
FI942765L (fi) * 1991-12-11 1994-06-10 Procter & Gamble Setyylipyridiniumkloridi ja domifeenibromidi orgaanisessa liottimessa
ZA932273B (en) * 1992-03-30 1993-11-26 Alza Corp Additives for bioerodible polymers to regulate degradation
US5540912A (en) * 1992-03-30 1996-07-30 Alza Corporation Viscous suspensions of controlled-release drug particles
US5759566A (en) * 1992-07-28 1998-06-02 Poli Industria Chimica Spa Microemulsion pharmaceutical compositions for the delivery of pharmaceutically active agents
US5654000A (en) * 1992-07-28 1997-08-05 Poli Industria Chimica S.P.A. Pharmaceutical compositions for transmucosal delivery of peptides
IT1255460B (it) * 1992-07-28 1995-11-02 Poli Ind Chimica Spa Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive
US6531156B1 (en) 1994-04-15 2003-03-11 Temple University Aqueous solven encapsulation method, apparatus and microcapsules
WO1995028227A1 (en) * 1994-04-15 1995-10-26 Temple University Aqueous solvent encapsulation method, apparatus and microcapsules
US5616315A (en) * 1994-10-13 1997-04-01 Gillette Canada Inc. Particles including degradable material and anti-microbial agent
TW412425B (en) * 1994-10-18 2000-11-21 Kao Corp Dentifrice composition having capsule particles
US5660817A (en) * 1994-11-09 1997-08-26 Gillette Canada, Inc. Desensitizing teeth with degradable particles
WO1997044016A1 (en) * 1996-05-23 1997-11-27 Samyang Corporation Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
KR100232645B1 (ko) * 1997-05-22 1999-12-01 김윤 국소 투여형 생분해성 서방형 치주염 치료제 조성물 및 그 제조 방법
DE29908415U1 (de) * 1999-05-18 1999-07-22 Carl, Wolfgang, Dr.med.dent., 66386 St Ingbert Mittel zur Behandlung lokaler parodontaler Infektionen
WO2001043698A1 (en) * 1999-12-15 2001-06-21 Carter Donald R Topical ointment
US7160931B2 (en) * 2000-03-15 2007-01-09 Yu-Ling Cheng Thermally reversible implant and filler
US6676958B2 (en) * 2001-06-19 2004-01-13 Advanced Bioadjuvants, Llc Adjuvant composition for mucosal and injection delivered vaccines
US20030198682A1 (en) * 2002-02-12 2003-10-23 Gruber James V. Composition and method for protecting labile active components during high temperature drying
US20040091432A1 (en) * 2002-11-04 2004-05-13 Dulin Jacques M. Oral hygiene system and method of treatment
CA2523484A1 (en) * 2003-05-02 2004-11-11 Rimon Therapeutics Ltd. Thermally reversible implant
CA2589701C (en) * 2004-12-08 2013-04-16 Tycho J. Speaker Microencapsulation product and process
GB0427520D0 (en) * 2004-12-16 2005-01-19 Univ Hull Magnetic resonance contrast media
JP5059760B2 (ja) * 2005-07-28 2012-10-31 ユニバーシティ オブ ハル スポロポレニンを含有する外皮を含む局所用配合物、生成物、およびその使用方法
JP5513111B2 (ja) * 2006-07-20 2014-06-04 イズン ファーマシューティカルズ コーポレイション フィルム送達リンス
US20080292663A1 (en) * 2007-05-22 2008-11-27 Gerber Jay D Adjuvant compositions and methods for delivering vaccines
GB0812513D0 (en) * 2008-07-09 2008-08-13 Univ Hull Delivery vehicle
MX2011001812A (es) * 2008-08-18 2011-07-29 Nanotherapeutics Inc Composicion topica de hidrogel.
AU2013204906B2 (en) 2012-03-12 2016-01-07 Advanced Bioadjuvants, Llc Adjuvant and vaccine compositions
US9744106B2 (en) 2013-05-28 2017-08-29 Capsulent Products containing charged polymer complex microcapsules and method of use
US11266685B2 (en) * 2014-06-09 2022-03-08 Klox Technologies Inc. Silicone-based biophotonic compositions and uses thereof
DE102016101280A1 (de) * 2016-01-26 2017-07-27 Frank Bröseler Pharmazeutische Zusammensetzung
CA3079828A1 (en) * 2017-11-01 2019-05-09 Merck Sharp & Dohme Corp. Stable formulations of cytomegalovirus

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959457A (en) * 1970-06-05 1976-05-25 Temple University Microparticulate material and method of making such material
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
US4145408A (en) * 1976-08-16 1979-03-20 The Procter & Gamble Company Controlled release article
US4164560A (en) * 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4485054A (en) * 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
GB8421706D0 (en) * 1984-08-28 1984-10-03 Pharmaceutical Holdings Ltd Pharmaceutical preparations
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form
US4743583A (en) * 1987-07-20 1988-05-10 Temple University Sustained release protein compositions and method for making

Also Published As

Publication number Publication date
ZA894308B (en) 1990-02-28
WO1990000048A1 (en) 1990-01-11
AU613298B2 (en) 1991-07-25
EP0393164A4 (en) 1991-07-03
JPH03501485A (ja) 1991-04-04
EP0393164A1 (en) 1990-10-24
DK51590D0 (da) 1990-02-27
NZ229356A (en) 1991-02-26
PT90994A (pt) 1989-12-29
AU3851889A (en) 1990-01-23
US4917892A (en) 1990-04-17

Similar Documents

Publication Publication Date Title
DK51590D0 (da) System til topisk afgivelse
FI931981L (fi) Hopmonterbart konstruktionssystem
DK313589D0 (da) Formastersystem
DK453585A (da) Laegemiddel-indgivelsessystem
DE68926340D1 (de) Frankiersystem
NO894666D0 (no) Elektroakustisk system.
FI894688A0 (fi) Flytande oralt tagbart terapeutiskt system.
DE3650223D1 (de) Flockenbelieferungsanlage.
FI901125A0 (fi) Smakgivande system foer fettfria livsmedel.
DE68928774D1 (de) Kamarasystem
FI901753A7 (fi) Lääkeaineita
DE68924369D1 (de) Mikroprozessorsystem.
DE68919919D1 (de) Anzeigesystem.
DK593889A (da) Elektroakustisk system
DE68920870D1 (de) Tastaturbedientes system.
FI901754A7 (fi) Lääkeaineita
NO900927D0 (no) Topisk avleveringssystem.
NO901018L (no) Topisk hematopofyrin.
DK52590D0 (da) Afgivelseslukke
DK678488D0 (da) Byggesystem
SE8903122D0 (sv) System
IT8818406V0 (it) Totomatik system electronix
IT8816905A0 (it) Totomatik system electronix
FI900579A7 (fi) Interaktiivinen pumppujärjestelmä
NO885230D0 (no) Bgekraft-system.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment